Global Chimeric Antigen Receptor Cell Therapy Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Chimeric Antigen Receptor Cell Therapy Industry Forecast” looks at past sales and reviews total world Chimeric Antigen Receptor Cell Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Chimeric Antigen Receptor Cell Therapy sales for 2023 through 2029. With Chimeric Antigen Receptor Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chimeric Antigen Receptor Cell Therapy industry.
This Insight Report provides a comprehensive analysis of the global Chimeric Antigen Receptor Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chimeric Antigen Receptor Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Chimeric Antigen Receptor Cell Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chimeric Antigen Receptor Cell Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chimeric Antigen Receptor Cell Therapy.
The global Chimeric Antigen Receptor Cell Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Chimeric Antigen Receptor Cell Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Chimeric Antigen Receptor Cell Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Chimeric Antigen Receptor Cell Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Chimeric Antigen Receptor Cell Therapy players cover Amgen Inc, Autolus Therapeutics Plc, Beijing Immunochina Medical Science & Technology Co Ltd, Bellicum Pharmaceuticals Inc, Bristol-Myers Squibb Co, bluebird bio Inc, CARsgen Therapeutics Ltd, Celgene Corp and Cell Medica Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Chimeric Antigen Receptor Cell Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
LPI (LP Information)' newest research report, the “Chimeric Antigen Receptor Cell Therapy Industry Forecast” looks at past sales and reviews total world Chimeric Antigen Receptor Cell Therapy sales in 2022, providing a comprehensive analysis by region and market sector of projected Chimeric Antigen Receptor Cell Therapy sales for 2023 through 2029. With Chimeric Antigen Receptor Cell Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chimeric Antigen Receptor Cell Therapy industry.
This Insight Report provides a comprehensive analysis of the global Chimeric Antigen Receptor Cell Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chimeric Antigen Receptor Cell Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Chimeric Antigen Receptor Cell Therapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chimeric Antigen Receptor Cell Therapy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chimeric Antigen Receptor Cell Therapy.
The global Chimeric Antigen Receptor Cell Therapy market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Chimeric Antigen Receptor Cell Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Chimeric Antigen Receptor Cell Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Chimeric Antigen Receptor Cell Therapy is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Chimeric Antigen Receptor Cell Therapy players cover Amgen Inc, Autolus Therapeutics Plc, Beijing Immunochina Medical Science & Technology Co Ltd, Bellicum Pharmaceuticals Inc, Bristol-Myers Squibb Co, bluebird bio Inc, CARsgen Therapeutics Ltd, Celgene Corp and Cell Medica Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Chimeric Antigen Receptor Cell Therapy market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Monotherapy
- Combination Therapy
- Acute Leukemia
- Non-hodgkin's Lymphoma
- Multiple Myeloma
- Transplant Rejection
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Amgen Inc
- Autolus Therapeutics Plc
- Beijing Immunochina Medical Science & Technology Co Ltd
- Bellicum Pharmaceuticals Inc
- Bristol-Myers Squibb Co
- bluebird bio Inc
- CARsgen Therapeutics Ltd
- Celgene Corp
- Cell Medica Ltd
- Cellular Biomedicine Group Inc
- Celularity Inc
- Celyad SA
- Daiichi Sankyo Co Ltd
- Fosun Pharmaceutical AG
- Gilead Sciences Inc
- Guangzhou Anjie Biomedical Technology Co Ltd
- Hangzhou Converd Co Ltd
- Hebei Senlang Biotechnology Inc Ltd
- HRAIN Biotechnology Co Ltd
- Juno Therapeutics Inc
- Kite Pharma Inc
- Nanjing Legend Biotech Co Ltd
- NantKwest Inc
- Nkarta Inc
- Novartis AG
- Ono Pharmaceutical Co Ltd
- Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
- Sorrento Therapeutics Inc
- Takara Bio Inc
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Chimeric Antigen Receptor Cell Therapy Market Size 2018-2029
2.1.2 Chimeric Antigen Receptor Cell Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Chimeric Antigen Receptor Cell Therapy Segment by Type
2.2.1 Monotherapy
2.2.2 Combination Therapy
2.3 Chimeric Antigen Receptor Cell Therapy Market Size by Type
2.3.1 Chimeric Antigen Receptor Cell Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2018-2023)
2.4 Chimeric Antigen Receptor Cell Therapy Segment by Application
2.4.1 Acute Leukemia
2.4.2 Non-hodgkin's Lymphoma
2.4.3 Multiple Myeloma
2.4.4 Transplant Rejection
2.4.5 Other
2.5 Chimeric Antigen Receptor Cell Therapy Market Size by Application
2.5.1 Chimeric Antigen Receptor Cell Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2018-2023)
3 CHIMERIC ANTIGEN RECEPTOR CELL THERAPY MARKET SIZE BY PLAYER
3.1 Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Players
3.1.1 Global Chimeric Antigen Receptor Cell Therapy Revenue by Players (2018-2023)
3.1.2 Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Chimeric Antigen Receptor Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CHIMERIC ANTIGEN RECEPTOR CELL THERAPY BY REGIONS
4.1 Chimeric Antigen Receptor Cell Therapy Market Size by Regions (2018-2023)
4.2 Americas Chimeric Antigen Receptor Cell Therapy Market Size Growth (2018-2023)
4.3 APAC Chimeric Antigen Receptor Cell Therapy Market Size Growth (2018-2023)
4.4 Europe Chimeric Antigen Receptor Cell Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Chimeric Antigen Receptor Cell Therapy Market Size by Country (2018-2023)
5.2 Americas Chimeric Antigen Receptor Cell Therapy Market Size by Type (2018-2023)
5.3 Americas Chimeric Antigen Receptor Cell Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chimeric Antigen Receptor Cell Therapy Market Size by Region (2018-2023)
6.2 APAC Chimeric Antigen Receptor Cell Therapy Market Size by Type (2018-2023)
6.3 APAC Chimeric Antigen Receptor Cell Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Chimeric Antigen Receptor Cell Therapy by Country (2018-2023)
7.2 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type (2018-2023)
7.3 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Chimeric Antigen Receptor Cell Therapy by Region (2018-2023)
8.2 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CHIMERIC ANTIGEN RECEPTOR CELL THERAPY MARKET FORECAST
10.1 Global Chimeric Antigen Receptor Cell Therapy Forecast by Regions (2024-2029)
10.1.1 Global Chimeric Antigen Receptor Cell Therapy Forecast by Regions (2024-2029)
10.1.2 Americas Chimeric Antigen Receptor Cell Therapy Forecast
10.1.3 APAC Chimeric Antigen Receptor Cell Therapy Forecast
10.1.4 Europe Chimeric Antigen Receptor Cell Therapy Forecast
10.1.5 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Forecast
10.2 Americas Chimeric Antigen Receptor Cell Therapy Forecast by Country (2024-2029)
10.2.1 United States Chimeric Antigen Receptor Cell Therapy Market Forecast
10.2.2 Canada Chimeric Antigen Receptor Cell Therapy Market Forecast
10.2.3 Mexico Chimeric Antigen Receptor Cell Therapy Market Forecast
10.2.4 Brazil Chimeric Antigen Receptor Cell Therapy Market Forecast
10.3 APAC Chimeric Antigen Receptor Cell Therapy Forecast by Region (2024-2029)
10.3.1 China Chimeric Antigen Receptor Cell Therapy Market Forecast
10.3.2 Japan Chimeric Antigen Receptor Cell Therapy Market Forecast
10.3.3 Korea Chimeric Antigen Receptor Cell Therapy Market Forecast
10.3.4 Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Forecast
10.3.5 India Chimeric Antigen Receptor Cell Therapy Market Forecast
10.3.6 Australia Chimeric Antigen Receptor Cell Therapy Market Forecast
10.4 Europe Chimeric Antigen Receptor Cell Therapy Forecast by Country (2024-2029)
10.4.1 Germany Chimeric Antigen Receptor Cell Therapy Market Forecast
10.4.2 France Chimeric Antigen Receptor Cell Therapy Market Forecast
10.4.3 UK Chimeric Antigen Receptor Cell Therapy Market Forecast
10.4.4 Italy Chimeric Antigen Receptor Cell Therapy Market Forecast
10.4.5 Russia Chimeric Antigen Receptor Cell Therapy Market Forecast
10.5 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Forecast by Region (2024-2029)
10.5.1 Egypt Chimeric Antigen Receptor Cell Therapy Market Forecast
10.5.2 South Africa Chimeric Antigen Receptor Cell Therapy Market Forecast
10.5.3 Israel Chimeric Antigen Receptor Cell Therapy Market Forecast
10.5.4 Turkey Chimeric Antigen Receptor Cell Therapy Market Forecast
10.5.5 GCC Countries Chimeric Antigen Receptor Cell Therapy Market Forecast
10.6 Global Chimeric Antigen Receptor Cell Therapy Forecast by Type (2024-2029)
10.7 Global Chimeric Antigen Receptor Cell Therapy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Amgen Inc
11.1.1 Amgen Inc Company Information
11.1.2 Amgen Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.1.3 Amgen Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Amgen Inc Main Business Overview
11.1.5 Amgen Inc Latest Developments
11.2 Autolus Therapeutics Plc
11.2.1 Autolus Therapeutics Plc Company Information
11.2.2 Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Product Offered
11.2.3 Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Autolus Therapeutics Plc Main Business Overview
11.2.5 Autolus Therapeutics Plc Latest Developments
11.3 Beijing Immunochina Medical Science & Technology Co Ltd
11.3.1 Beijing Immunochina Medical Science & Technology Co Ltd Company Information
11.3.2 Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Beijing Immunochina Medical Science & Technology Co Ltd Main Business Overview
11.3.5 Beijing Immunochina Medical Science & Technology Co Ltd Latest Developments
11.4 Bellicum Pharmaceuticals Inc
11.4.1 Bellicum Pharmaceuticals Inc Company Information
11.4.2 Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.4.3 Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Bellicum Pharmaceuticals Inc Main Business Overview
11.4.5 Bellicum Pharmaceuticals Inc Latest Developments
11.5 Bristol-Myers Squibb Co
11.5.1 Bristol-Myers Squibb Co Company Information
11.5.2 Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Product Offered
11.5.3 Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Bristol-Myers Squibb Co Main Business Overview
11.5.5 Bristol-Myers Squibb Co Latest Developments
11.6 bluebird bio Inc
11.6.1 bluebird bio Inc Company Information
11.6.2 bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.6.3 bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 bluebird bio Inc Main Business Overview
11.6.5 bluebird bio Inc Latest Developments
11.7 CARsgen Therapeutics Ltd
11.7.1 CARsgen Therapeutics Ltd Company Information
11.7.2 CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.7.3 CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 CARsgen Therapeutics Ltd Main Business Overview
11.7.5 CARsgen Therapeutics Ltd Latest Developments
11.8 Celgene Corp
11.8.1 Celgene Corp Company Information
11.8.2 Celgene Corp Chimeric Antigen Receptor Cell Therapy Product Offered
11.8.3 Celgene Corp Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Celgene Corp Main Business Overview
11.8.5 Celgene Corp Latest Developments
11.9 Cell Medica Ltd
11.9.1 Cell Medica Ltd Company Information
11.9.2 Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.9.3 Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Cell Medica Ltd Main Business Overview
11.9.5 Cell Medica Ltd Latest Developments
11.10 Cellular Biomedicine Group Inc
11.10.1 Cellular Biomedicine Group Inc Company Information
11.10.2 Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.10.3 Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Cellular Biomedicine Group Inc Main Business Overview
11.10.5 Cellular Biomedicine Group Inc Latest Developments
11.11 Celularity Inc
11.11.1 Celularity Inc Company Information
11.11.2 Celularity Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.11.3 Celularity Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Celularity Inc Main Business Overview
11.11.5 Celularity Inc Latest Developments
11.12 Celyad SA
11.12.1 Celyad SA Company Information
11.12.2 Celyad SA Chimeric Antigen Receptor Cell Therapy Product Offered
11.12.3 Celyad SA Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Celyad SA Main Business Overview
11.12.5 Celyad SA Latest Developments
11.13 Daiichi Sankyo Co Ltd
11.13.1 Daiichi Sankyo Co Ltd Company Information
11.13.2 Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.13.3 Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Daiichi Sankyo Co Ltd Main Business Overview
11.13.5 Daiichi Sankyo Co Ltd Latest Developments
11.14 Fosun Pharmaceutical AG
11.14.1 Fosun Pharmaceutical AG Company Information
11.14.2 Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Product Offered
11.14.3 Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Fosun Pharmaceutical AG Main Business Overview
11.14.5 Fosun Pharmaceutical AG Latest Developments
11.15 Gilead Sciences Inc
11.15.1 Gilead Sciences Inc Company Information
11.15.2 Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.15.3 Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Gilead Sciences Inc Main Business Overview
11.15.5 Gilead Sciences Inc Latest Developments
11.16 Guangzhou Anjie Biomedical Technology Co Ltd
11.16.1 Guangzhou Anjie Biomedical Technology Co Ltd Company Information
11.16.2 Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Guangzhou Anjie Biomedical Technology Co Ltd Main Business Overview
11.16.5 Guangzhou Anjie Biomedical Technology Co Ltd Latest Developments
11.17 Hangzhou Converd Co Ltd
11.17.1 Hangzhou Converd Co Ltd Company Information
11.17.2 Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.17.3 Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Hangzhou Converd Co Ltd Main Business Overview
11.17.5 Hangzhou Converd Co Ltd Latest Developments
11.18 Hebei Senlang Biotechnology Inc Ltd
11.18.1 Hebei Senlang Biotechnology Inc Ltd Company Information
11.18.2 Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.18.3 Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Hebei Senlang Biotechnology Inc Ltd Main Business Overview
11.18.5 Hebei Senlang Biotechnology Inc Ltd Latest Developments
11.19 HRAIN Biotechnology Co Ltd
11.19.1 HRAIN Biotechnology Co Ltd Company Information
11.19.2 HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.19.3 HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 HRAIN Biotechnology Co Ltd Main Business Overview
11.19.5 HRAIN Biotechnology Co Ltd Latest Developments
11.20 Juno Therapeutics Inc
11.20.1 Juno Therapeutics Inc Company Information
11.20.2 Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.20.3 Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Juno Therapeutics Inc Main Business Overview
11.20.5 Juno Therapeutics Inc Latest Developments
11.21 Kite Pharma Inc
11.21.1 Kite Pharma Inc Company Information
11.21.2 Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.21.3 Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Kite Pharma Inc Main Business Overview
11.21.5 Kite Pharma Inc Latest Developments
11.22 Nanjing Legend Biotech Co Ltd
11.22.1 Nanjing Legend Biotech Co Ltd Company Information
11.22.2 Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.22.3 Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 Nanjing Legend Biotech Co Ltd Main Business Overview
11.22.5 Nanjing Legend Biotech Co Ltd Latest Developments
11.23 NantKwest Inc
11.23.1 NantKwest Inc Company Information
11.23.2 NantKwest Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.23.3 NantKwest Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.23.4 NantKwest Inc Main Business Overview
11.23.5 NantKwest Inc Latest Developments
11.24 Nkarta Inc
11.24.1 Nkarta Inc Company Information
11.24.2 Nkarta Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.24.3 Nkarta Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.24.4 Nkarta Inc Main Business Overview
11.24.5 Nkarta Inc Latest Developments
11.25 Novartis AG
11.25.1 Novartis AG Company Information
11.25.2 Novartis AG Chimeric Antigen Receptor Cell Therapy Product Offered
11.25.3 Novartis AG Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.25.4 Novartis AG Main Business Overview
11.25.5 Novartis AG Latest Developments
11.26 Ono Pharmaceutical Co Ltd
11.26.1 Ono Pharmaceutical Co Ltd Company Information
11.26.2 Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.26.3 Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.26.4 Ono Pharmaceutical Co Ltd Main Business Overview
11.26.5 Ono Pharmaceutical Co Ltd Latest Developments
11.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
11.27.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Information
11.27.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.27.4 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Main Business Overview
11.27.5 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Latest Developments
11.28 Sorrento Therapeutics Inc
11.28.1 Sorrento Therapeutics Inc Company Information
11.28.2 Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.28.3 Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.28.4 Sorrento Therapeutics Inc Main Business Overview
11.28.5 Sorrento Therapeutics Inc Latest Developments
11.29 Takara Bio Inc
11.29.1 Takara Bio Inc Company Information
11.29.2 Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.29.3 Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.29.4 Takara Bio Inc Main Business Overview
11.29.5 Takara Bio Inc Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Chimeric Antigen Receptor Cell Therapy Market Size 2018-2029
2.1.2 Chimeric Antigen Receptor Cell Therapy Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Chimeric Antigen Receptor Cell Therapy Segment by Type
2.2.1 Monotherapy
2.2.2 Combination Therapy
2.3 Chimeric Antigen Receptor Cell Therapy Market Size by Type
2.3.1 Chimeric Antigen Receptor Cell Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2018-2023)
2.4 Chimeric Antigen Receptor Cell Therapy Segment by Application
2.4.1 Acute Leukemia
2.4.2 Non-hodgkin's Lymphoma
2.4.3 Multiple Myeloma
2.4.4 Transplant Rejection
2.4.5 Other
2.5 Chimeric Antigen Receptor Cell Therapy Market Size by Application
2.5.1 Chimeric Antigen Receptor Cell Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2018-2023)
3 CHIMERIC ANTIGEN RECEPTOR CELL THERAPY MARKET SIZE BY PLAYER
3.1 Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Players
3.1.1 Global Chimeric Antigen Receptor Cell Therapy Revenue by Players (2018-2023)
3.1.2 Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Chimeric Antigen Receptor Cell Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CHIMERIC ANTIGEN RECEPTOR CELL THERAPY BY REGIONS
4.1 Chimeric Antigen Receptor Cell Therapy Market Size by Regions (2018-2023)
4.2 Americas Chimeric Antigen Receptor Cell Therapy Market Size Growth (2018-2023)
4.3 APAC Chimeric Antigen Receptor Cell Therapy Market Size Growth (2018-2023)
4.4 Europe Chimeric Antigen Receptor Cell Therapy Market Size Growth (2018-2023)
4.5 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Chimeric Antigen Receptor Cell Therapy Market Size by Country (2018-2023)
5.2 Americas Chimeric Antigen Receptor Cell Therapy Market Size by Type (2018-2023)
5.3 Americas Chimeric Antigen Receptor Cell Therapy Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chimeric Antigen Receptor Cell Therapy Market Size by Region (2018-2023)
6.2 APAC Chimeric Antigen Receptor Cell Therapy Market Size by Type (2018-2023)
6.3 APAC Chimeric Antigen Receptor Cell Therapy Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Chimeric Antigen Receptor Cell Therapy by Country (2018-2023)
7.2 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type (2018-2023)
7.3 Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Chimeric Antigen Receptor Cell Therapy by Region (2018-2023)
8.2 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Type (2018-2023)
8.3 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CHIMERIC ANTIGEN RECEPTOR CELL THERAPY MARKET FORECAST
10.1 Global Chimeric Antigen Receptor Cell Therapy Forecast by Regions (2024-2029)
10.1.1 Global Chimeric Antigen Receptor Cell Therapy Forecast by Regions (2024-2029)
10.1.2 Americas Chimeric Antigen Receptor Cell Therapy Forecast
10.1.3 APAC Chimeric Antigen Receptor Cell Therapy Forecast
10.1.4 Europe Chimeric Antigen Receptor Cell Therapy Forecast
10.1.5 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Forecast
10.2 Americas Chimeric Antigen Receptor Cell Therapy Forecast by Country (2024-2029)
10.2.1 United States Chimeric Antigen Receptor Cell Therapy Market Forecast
10.2.2 Canada Chimeric Antigen Receptor Cell Therapy Market Forecast
10.2.3 Mexico Chimeric Antigen Receptor Cell Therapy Market Forecast
10.2.4 Brazil Chimeric Antigen Receptor Cell Therapy Market Forecast
10.3 APAC Chimeric Antigen Receptor Cell Therapy Forecast by Region (2024-2029)
10.3.1 China Chimeric Antigen Receptor Cell Therapy Market Forecast
10.3.2 Japan Chimeric Antigen Receptor Cell Therapy Market Forecast
10.3.3 Korea Chimeric Antigen Receptor Cell Therapy Market Forecast
10.3.4 Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Forecast
10.3.5 India Chimeric Antigen Receptor Cell Therapy Market Forecast
10.3.6 Australia Chimeric Antigen Receptor Cell Therapy Market Forecast
10.4 Europe Chimeric Antigen Receptor Cell Therapy Forecast by Country (2024-2029)
10.4.1 Germany Chimeric Antigen Receptor Cell Therapy Market Forecast
10.4.2 France Chimeric Antigen Receptor Cell Therapy Market Forecast
10.4.3 UK Chimeric Antigen Receptor Cell Therapy Market Forecast
10.4.4 Italy Chimeric Antigen Receptor Cell Therapy Market Forecast
10.4.5 Russia Chimeric Antigen Receptor Cell Therapy Market Forecast
10.5 Middle East & Africa Chimeric Antigen Receptor Cell Therapy Forecast by Region (2024-2029)
10.5.1 Egypt Chimeric Antigen Receptor Cell Therapy Market Forecast
10.5.2 South Africa Chimeric Antigen Receptor Cell Therapy Market Forecast
10.5.3 Israel Chimeric Antigen Receptor Cell Therapy Market Forecast
10.5.4 Turkey Chimeric Antigen Receptor Cell Therapy Market Forecast
10.5.5 GCC Countries Chimeric Antigen Receptor Cell Therapy Market Forecast
10.6 Global Chimeric Antigen Receptor Cell Therapy Forecast by Type (2024-2029)
10.7 Global Chimeric Antigen Receptor Cell Therapy Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Amgen Inc
11.1.1 Amgen Inc Company Information
11.1.2 Amgen Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.1.3 Amgen Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Amgen Inc Main Business Overview
11.1.5 Amgen Inc Latest Developments
11.2 Autolus Therapeutics Plc
11.2.1 Autolus Therapeutics Plc Company Information
11.2.2 Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Product Offered
11.2.3 Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Autolus Therapeutics Plc Main Business Overview
11.2.5 Autolus Therapeutics Plc Latest Developments
11.3 Beijing Immunochina Medical Science & Technology Co Ltd
11.3.1 Beijing Immunochina Medical Science & Technology Co Ltd Company Information
11.3.2 Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.3.3 Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Beijing Immunochina Medical Science & Technology Co Ltd Main Business Overview
11.3.5 Beijing Immunochina Medical Science & Technology Co Ltd Latest Developments
11.4 Bellicum Pharmaceuticals Inc
11.4.1 Bellicum Pharmaceuticals Inc Company Information
11.4.2 Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.4.3 Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Bellicum Pharmaceuticals Inc Main Business Overview
11.4.5 Bellicum Pharmaceuticals Inc Latest Developments
11.5 Bristol-Myers Squibb Co
11.5.1 Bristol-Myers Squibb Co Company Information
11.5.2 Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Product Offered
11.5.3 Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Bristol-Myers Squibb Co Main Business Overview
11.5.5 Bristol-Myers Squibb Co Latest Developments
11.6 bluebird bio Inc
11.6.1 bluebird bio Inc Company Information
11.6.2 bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.6.3 bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 bluebird bio Inc Main Business Overview
11.6.5 bluebird bio Inc Latest Developments
11.7 CARsgen Therapeutics Ltd
11.7.1 CARsgen Therapeutics Ltd Company Information
11.7.2 CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.7.3 CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 CARsgen Therapeutics Ltd Main Business Overview
11.7.5 CARsgen Therapeutics Ltd Latest Developments
11.8 Celgene Corp
11.8.1 Celgene Corp Company Information
11.8.2 Celgene Corp Chimeric Antigen Receptor Cell Therapy Product Offered
11.8.3 Celgene Corp Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Celgene Corp Main Business Overview
11.8.5 Celgene Corp Latest Developments
11.9 Cell Medica Ltd
11.9.1 Cell Medica Ltd Company Information
11.9.2 Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.9.3 Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Cell Medica Ltd Main Business Overview
11.9.5 Cell Medica Ltd Latest Developments
11.10 Cellular Biomedicine Group Inc
11.10.1 Cellular Biomedicine Group Inc Company Information
11.10.2 Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.10.3 Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Cellular Biomedicine Group Inc Main Business Overview
11.10.5 Cellular Biomedicine Group Inc Latest Developments
11.11 Celularity Inc
11.11.1 Celularity Inc Company Information
11.11.2 Celularity Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.11.3 Celularity Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Celularity Inc Main Business Overview
11.11.5 Celularity Inc Latest Developments
11.12 Celyad SA
11.12.1 Celyad SA Company Information
11.12.2 Celyad SA Chimeric Antigen Receptor Cell Therapy Product Offered
11.12.3 Celyad SA Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Celyad SA Main Business Overview
11.12.5 Celyad SA Latest Developments
11.13 Daiichi Sankyo Co Ltd
11.13.1 Daiichi Sankyo Co Ltd Company Information
11.13.2 Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.13.3 Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Daiichi Sankyo Co Ltd Main Business Overview
11.13.5 Daiichi Sankyo Co Ltd Latest Developments
11.14 Fosun Pharmaceutical AG
11.14.1 Fosun Pharmaceutical AG Company Information
11.14.2 Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Product Offered
11.14.3 Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Fosun Pharmaceutical AG Main Business Overview
11.14.5 Fosun Pharmaceutical AG Latest Developments
11.15 Gilead Sciences Inc
11.15.1 Gilead Sciences Inc Company Information
11.15.2 Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.15.3 Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Gilead Sciences Inc Main Business Overview
11.15.5 Gilead Sciences Inc Latest Developments
11.16 Guangzhou Anjie Biomedical Technology Co Ltd
11.16.1 Guangzhou Anjie Biomedical Technology Co Ltd Company Information
11.16.2 Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.16.3 Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 Guangzhou Anjie Biomedical Technology Co Ltd Main Business Overview
11.16.5 Guangzhou Anjie Biomedical Technology Co Ltd Latest Developments
11.17 Hangzhou Converd Co Ltd
11.17.1 Hangzhou Converd Co Ltd Company Information
11.17.2 Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.17.3 Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Hangzhou Converd Co Ltd Main Business Overview
11.17.5 Hangzhou Converd Co Ltd Latest Developments
11.18 Hebei Senlang Biotechnology Inc Ltd
11.18.1 Hebei Senlang Biotechnology Inc Ltd Company Information
11.18.2 Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.18.3 Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Hebei Senlang Biotechnology Inc Ltd Main Business Overview
11.18.5 Hebei Senlang Biotechnology Inc Ltd Latest Developments
11.19 HRAIN Biotechnology Co Ltd
11.19.1 HRAIN Biotechnology Co Ltd Company Information
11.19.2 HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.19.3 HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 HRAIN Biotechnology Co Ltd Main Business Overview
11.19.5 HRAIN Biotechnology Co Ltd Latest Developments
11.20 Juno Therapeutics Inc
11.20.1 Juno Therapeutics Inc Company Information
11.20.2 Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.20.3 Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 Juno Therapeutics Inc Main Business Overview
11.20.5 Juno Therapeutics Inc Latest Developments
11.21 Kite Pharma Inc
11.21.1 Kite Pharma Inc Company Information
11.21.2 Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.21.3 Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Kite Pharma Inc Main Business Overview
11.21.5 Kite Pharma Inc Latest Developments
11.22 Nanjing Legend Biotech Co Ltd
11.22.1 Nanjing Legend Biotech Co Ltd Company Information
11.22.2 Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.22.3 Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.22.4 Nanjing Legend Biotech Co Ltd Main Business Overview
11.22.5 Nanjing Legend Biotech Co Ltd Latest Developments
11.23 NantKwest Inc
11.23.1 NantKwest Inc Company Information
11.23.2 NantKwest Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.23.3 NantKwest Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.23.4 NantKwest Inc Main Business Overview
11.23.5 NantKwest Inc Latest Developments
11.24 Nkarta Inc
11.24.1 Nkarta Inc Company Information
11.24.2 Nkarta Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.24.3 Nkarta Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.24.4 Nkarta Inc Main Business Overview
11.24.5 Nkarta Inc Latest Developments
11.25 Novartis AG
11.25.1 Novartis AG Company Information
11.25.2 Novartis AG Chimeric Antigen Receptor Cell Therapy Product Offered
11.25.3 Novartis AG Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.25.4 Novartis AG Main Business Overview
11.25.5 Novartis AG Latest Developments
11.26 Ono Pharmaceutical Co Ltd
11.26.1 Ono Pharmaceutical Co Ltd Company Information
11.26.2 Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.26.3 Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.26.4 Ono Pharmaceutical Co Ltd Main Business Overview
11.26.5 Ono Pharmaceutical Co Ltd Latest Developments
11.27 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd
11.27.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Information
11.27.2 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
11.27.3 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.27.4 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Main Business Overview
11.27.5 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Latest Developments
11.28 Sorrento Therapeutics Inc
11.28.1 Sorrento Therapeutics Inc Company Information
11.28.2 Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.28.3 Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.28.4 Sorrento Therapeutics Inc Main Business Overview
11.28.5 Sorrento Therapeutics Inc Latest Developments
11.29 Takara Bio Inc
11.29.1 Takara Bio Inc Company Information
11.29.2 Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Product Offered
11.29.3 Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
11.29.4 Takara Bio Inc Main Business Overview
11.29.5 Takara Bio Inc Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Chimeric Antigen Receptor Cell Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Monotherapy
Table 3. Major Players of Combination Therapy
Table 4. Chimeric Antigen Receptor Cell Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Chimeric Antigen Receptor Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2018-2023)
Table 7. Chimeric Antigen Receptor Cell Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Chimeric Antigen Receptor Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2018-2023)
Table 10. Global Chimeric Antigen Receptor Cell Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Player (2018-2023)
Table 12. Chimeric Antigen Receptor Cell Therapy Key Players Head office and Products Offered
Table 13. Chimeric Antigen Receptor Cell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Chimeric Antigen Receptor Cell Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Regions (2018-2023)
Table 18. Global Chimeric Antigen Receptor Cell Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Chimeric Antigen Receptor Cell Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Country (2018-2023)
Table 22. Americas Chimeric Antigen Receptor Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2018-2023)
Table 24. Americas Chimeric Antigen Receptor Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2018-2023)
Table 26. APAC Chimeric Antigen Receptor Cell Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Region (2018-2023)
Table 28. APAC Chimeric Antigen Receptor Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2018-2023)
Table 30. APAC Chimeric Antigen Receptor Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2018-2023)
Table 32. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Country (2018-2023)
Table 34. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2018-2023)
Table 36. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Chimeric Antigen Receptor Cell Therapy
Table 45. Key Market Challenges & Risks of Chimeric Antigen Receptor Cell Therapy
Table 46. Key Industry Trends of Chimeric Antigen Receptor Cell Therapy
Table 47. Global Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Amgen Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 52. Amgen Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 53. Amgen Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Amgen Inc Main Business
Table 55. Amgen Inc Latest Developments
Table 56. Autolus Therapeutics Plc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 57. Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 58. Autolus Therapeutics Plc Main Business
Table 59. Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Autolus Therapeutics Plc Latest Developments
Table 61. Beijing Immunochina Medical Science & Technology Co Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 62. Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 63. Beijing Immunochina Medical Science & Technology Co Ltd Main Business
Table 64. Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Beijing Immunochina Medical Science & Technology Co Ltd Latest Developments
Table 66. Bellicum Pharmaceuticals Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 67. Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 68. Bellicum Pharmaceuticals Inc Main Business
Table 69. Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Bellicum Pharmaceuticals Inc Latest Developments
Table 71. Bristol-Myers Squibb Co Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 72. Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Product Offered
Table 73. Bristol-Myers Squibb Co Main Business
Table 74. Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Bristol-Myers Squibb Co Latest Developments
Table 76. bluebird bio Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 77. bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 78. bluebird bio Inc Main Business
Table 79. bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. bluebird bio Inc Latest Developments
Table 81. CARsgen Therapeutics Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 82. CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 83. CARsgen Therapeutics Ltd Main Business
Table 84. CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. CARsgen Therapeutics Ltd Latest Developments
Table 86. Celgene Corp Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 87. Celgene Corp Chimeric Antigen Receptor Cell Therapy Product Offered
Table 88. Celgene Corp Main Business
Table 89. Celgene Corp Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Celgene Corp Latest Developments
Table 91. Cell Medica Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 92. Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 93. Cell Medica Ltd Main Business
Table 94. Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Cell Medica Ltd Latest Developments
Table 96. Cellular Biomedicine Group Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 97. Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 98. Cellular Biomedicine Group Inc Main Business
Table 99. Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Cellular Biomedicine Group Inc Latest Developments
Table 101. Celularity Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 102. Celularity Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 103. Celularity Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Celularity Inc Main Business
Table 105. Celularity Inc Latest Developments
Table 106. Celyad SA Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 107. Celyad SA Chimeric Antigen Receptor Cell Therapy Product Offered
Table 108. Celyad SA Main Business
Table 109. Celyad SA Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Celyad SA Latest Developments
Table 111. Daiichi Sankyo Co Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 112. Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 113. Daiichi Sankyo Co Ltd Main Business
Table 114. Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Daiichi Sankyo Co Ltd Latest Developments
Table 116. Fosun Pharmaceutical AG Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 117. Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Product Offered
Table 118. Fosun Pharmaceutical AG Main Business
Table 119. Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Fosun Pharmaceutical AG Latest Developments
Table 121. Gilead Sciences Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 122. Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 123. Gilead Sciences Inc Main Business
Table 124. Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 125. Gilead Sciences Inc Latest Developments
Table 126. Guangzhou Anjie Biomedical Technology Co Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 127. Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 128. Guangzhou Anjie Biomedical Technology Co Ltd Main Business
Table 129. Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 130. Guangzhou Anjie Biomedical Technology Co Ltd Latest Developments
Table 131. Hangzhou Converd Co Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 132. Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 133. Hangzhou Converd Co Ltd Main Business
Table 134. Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 135. Hangzhou Converd Co Ltd Latest Developments
Table 136. Hebei Senlang Biotechnology Inc Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 137. Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 138. Hebei Senlang Biotechnology Inc Ltd Main Business
Table 139. Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 140. Hebei Senlang Biotechnology Inc Ltd Latest Developments
Table 141. HRAIN Biotechnology Co Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 142. HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 143. HRAIN Biotechnology Co Ltd Main Business
Table 144. HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 145. HRAIN Biotechnology Co Ltd Latest Developments
Table 146. Juno Therapeutics Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 147. Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 148. Juno Therapeutics Inc Main Business
Table 149. Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 150. Juno Therapeutics Inc Latest Developments
Table 151. Kite Pharma Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 152. Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 153. Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 154. Kite Pharma Inc Main Business
Table 155. Kite Pharma Inc Latest Developments
Table 156. Nanjing Legend Biotech Co Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 157. Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 158. Nanjing Legend Biotech Co Ltd Main Business
Table 159. Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 160. Nanjing Legend Biotech Co Ltd Latest Developments
Table 161. NantKwest Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 162. NantKwest Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 163. NantKwest Inc Main Business
Table 164. NantKwest Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 165. NantKwest Inc Latest Developments
Table 166. Nkarta Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 167. Nkarta Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 168. Nkarta Inc Main Business
Table 169. Nkarta Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 170. Nkarta Inc Latest Developments
Table 171. Novartis AG Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 172. Novartis AG Chimeric Antigen Receptor Cell Therapy Product Offered
Table 173. Novartis AG Main Business
Table 174. Novartis AG Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 175. Novartis AG Latest Developments
Table 176. Ono Pharmaceutical Co Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 177. Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 178. Ono Pharmaceutical Co Ltd Main Business
Table 179. Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 180. Ono Pharmaceutical Co Ltd Latest Developments
Table 181. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 182. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 183. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Main Business
Table 184. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 185. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Latest Developments
Table 186. Sorrento Therapeutics Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 187. Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 188. Sorrento Therapeutics Inc Main Business
Table 189. Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 190. Sorrento Therapeutics Inc Latest Developments
Table 191. Takara Bio Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 192. Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 193. Takara Bio Inc Main Business
Table 194. Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 195. Takara Bio Inc Latest Developments
Table 1. Chimeric Antigen Receptor Cell Therapy Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Monotherapy
Table 3. Major Players of Combination Therapy
Table 4. Chimeric Antigen Receptor Cell Therapy Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Chimeric Antigen Receptor Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2018-2023)
Table 7. Chimeric Antigen Receptor Cell Therapy Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Chimeric Antigen Receptor Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2018-2023)
Table 10. Global Chimeric Antigen Receptor Cell Therapy Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Player (2018-2023)
Table 12. Chimeric Antigen Receptor Cell Therapy Key Players Head office and Products Offered
Table 13. Chimeric Antigen Receptor Cell Therapy Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Chimeric Antigen Receptor Cell Therapy Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Regions (2018-2023)
Table 18. Global Chimeric Antigen Receptor Cell Therapy Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Chimeric Antigen Receptor Cell Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Country (2018-2023)
Table 22. Americas Chimeric Antigen Receptor Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2018-2023)
Table 24. Americas Chimeric Antigen Receptor Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2018-2023)
Table 26. APAC Chimeric Antigen Receptor Cell Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Region (2018-2023)
Table 28. APAC Chimeric Antigen Receptor Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2018-2023)
Table 30. APAC Chimeric Antigen Receptor Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2018-2023)
Table 32. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Country (2018-2023)
Table 34. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2018-2023)
Table 36. Europe Chimeric Antigen Receptor Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Chimeric Antigen Receptor Cell Therapy
Table 45. Key Market Challenges & Risks of Chimeric Antigen Receptor Cell Therapy
Table 46. Key Industry Trends of Chimeric Antigen Receptor Cell Therapy
Table 47. Global Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Chimeric Antigen Receptor Cell Therapy Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Amgen Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 52. Amgen Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 53. Amgen Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Amgen Inc Main Business
Table 55. Amgen Inc Latest Developments
Table 56. Autolus Therapeutics Plc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 57. Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 58. Autolus Therapeutics Plc Main Business
Table 59. Autolus Therapeutics Plc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Autolus Therapeutics Plc Latest Developments
Table 61. Beijing Immunochina Medical Science & Technology Co Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 62. Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 63. Beijing Immunochina Medical Science & Technology Co Ltd Main Business
Table 64. Beijing Immunochina Medical Science & Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Beijing Immunochina Medical Science & Technology Co Ltd Latest Developments
Table 66. Bellicum Pharmaceuticals Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 67. Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 68. Bellicum Pharmaceuticals Inc Main Business
Table 69. Bellicum Pharmaceuticals Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Bellicum Pharmaceuticals Inc Latest Developments
Table 71. Bristol-Myers Squibb Co Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 72. Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Product Offered
Table 73. Bristol-Myers Squibb Co Main Business
Table 74. Bristol-Myers Squibb Co Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Bristol-Myers Squibb Co Latest Developments
Table 76. bluebird bio Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 77. bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 78. bluebird bio Inc Main Business
Table 79. bluebird bio Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. bluebird bio Inc Latest Developments
Table 81. CARsgen Therapeutics Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 82. CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 83. CARsgen Therapeutics Ltd Main Business
Table 84. CARsgen Therapeutics Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. CARsgen Therapeutics Ltd Latest Developments
Table 86. Celgene Corp Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 87. Celgene Corp Chimeric Antigen Receptor Cell Therapy Product Offered
Table 88. Celgene Corp Main Business
Table 89. Celgene Corp Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Celgene Corp Latest Developments
Table 91. Cell Medica Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 92. Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 93. Cell Medica Ltd Main Business
Table 94. Cell Medica Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Cell Medica Ltd Latest Developments
Table 96. Cellular Biomedicine Group Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 97. Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 98. Cellular Biomedicine Group Inc Main Business
Table 99. Cellular Biomedicine Group Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Cellular Biomedicine Group Inc Latest Developments
Table 101. Celularity Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 102. Celularity Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 103. Celularity Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Celularity Inc Main Business
Table 105. Celularity Inc Latest Developments
Table 106. Celyad SA Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 107. Celyad SA Chimeric Antigen Receptor Cell Therapy Product Offered
Table 108. Celyad SA Main Business
Table 109. Celyad SA Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Celyad SA Latest Developments
Table 111. Daiichi Sankyo Co Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 112. Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 113. Daiichi Sankyo Co Ltd Main Business
Table 114. Daiichi Sankyo Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Daiichi Sankyo Co Ltd Latest Developments
Table 116. Fosun Pharmaceutical AG Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 117. Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Product Offered
Table 118. Fosun Pharmaceutical AG Main Business
Table 119. Fosun Pharmaceutical AG Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 120. Fosun Pharmaceutical AG Latest Developments
Table 121. Gilead Sciences Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 122. Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 123. Gilead Sciences Inc Main Business
Table 124. Gilead Sciences Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 125. Gilead Sciences Inc Latest Developments
Table 126. Guangzhou Anjie Biomedical Technology Co Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 127. Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 128. Guangzhou Anjie Biomedical Technology Co Ltd Main Business
Table 129. Guangzhou Anjie Biomedical Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 130. Guangzhou Anjie Biomedical Technology Co Ltd Latest Developments
Table 131. Hangzhou Converd Co Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 132. Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 133. Hangzhou Converd Co Ltd Main Business
Table 134. Hangzhou Converd Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 135. Hangzhou Converd Co Ltd Latest Developments
Table 136. Hebei Senlang Biotechnology Inc Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 137. Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 138. Hebei Senlang Biotechnology Inc Ltd Main Business
Table 139. Hebei Senlang Biotechnology Inc Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 140. Hebei Senlang Biotechnology Inc Ltd Latest Developments
Table 141. HRAIN Biotechnology Co Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 142. HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 143. HRAIN Biotechnology Co Ltd Main Business
Table 144. HRAIN Biotechnology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 145. HRAIN Biotechnology Co Ltd Latest Developments
Table 146. Juno Therapeutics Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 147. Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 148. Juno Therapeutics Inc Main Business
Table 149. Juno Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 150. Juno Therapeutics Inc Latest Developments
Table 151. Kite Pharma Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 152. Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 153. Kite Pharma Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 154. Kite Pharma Inc Main Business
Table 155. Kite Pharma Inc Latest Developments
Table 156. Nanjing Legend Biotech Co Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 157. Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 158. Nanjing Legend Biotech Co Ltd Main Business
Table 159. Nanjing Legend Biotech Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 160. Nanjing Legend Biotech Co Ltd Latest Developments
Table 161. NantKwest Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 162. NantKwest Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 163. NantKwest Inc Main Business
Table 164. NantKwest Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 165. NantKwest Inc Latest Developments
Table 166. Nkarta Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 167. Nkarta Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 168. Nkarta Inc Main Business
Table 169. Nkarta Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 170. Nkarta Inc Latest Developments
Table 171. Novartis AG Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 172. Novartis AG Chimeric Antigen Receptor Cell Therapy Product Offered
Table 173. Novartis AG Main Business
Table 174. Novartis AG Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 175. Novartis AG Latest Developments
Table 176. Ono Pharmaceutical Co Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 177. Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 178. Ono Pharmaceutical Co Ltd Main Business
Table 179. Ono Pharmaceutical Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 180. Ono Pharmaceutical Co Ltd Latest Developments
Table 181. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 182. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Product Offered
Table 183. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Main Business
Table 184. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 185. Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Latest Developments
Table 186. Sorrento Therapeutics Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 187. Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 188. Sorrento Therapeutics Inc Main Business
Table 189. Sorrento Therapeutics Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 190. Sorrento Therapeutics Inc Latest Developments
Table 191. Takara Bio Inc Details, Company Type, Chimeric Antigen Receptor Cell Therapy Area Served and Its Competitors
Table 192. Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Product Offered
Table 193. Takara Bio Inc Main Business
Table 194. Takara Bio Inc Chimeric Antigen Receptor Cell Therapy Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 195. Takara Bio Inc Latest Developments
LIST OF FIGURES
Figure 1. Chimeric Antigen Receptor Cell Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Chimeric Antigen Receptor Cell Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Chimeric Antigen Receptor Cell Therapy Sales Market Share by Country/Region (2022)
Figure 8. Chimeric Antigen Receptor Cell Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type in 2022
Figure 10. Chimeric Antigen Receptor Cell Therapy in Acute Leukemia
Figure 11. Global Chimeric Antigen Receptor Cell Therapy Market: Acute Leukemia (2018-2023) & ($ Millions)
Figure 12. Chimeric Antigen Receptor Cell Therapy in Non-hodgkin's Lymphoma
Figure 13. Global Chimeric Antigen Receptor Cell Therapy Market: Non-hodgkin's Lymphoma (2018-2023) & ($ Millions)
Figure 14. Chimeric Antigen Receptor Cell Therapy in Multiple Myeloma
Figure 15. Global Chimeric Antigen Receptor Cell Therapy Market: Multiple Myeloma (2018-2023) & ($ Millions)
Figure 16. Chimeric Antigen Receptor Cell Therapy in Transplant Rejection
Figure 17. Global Chimeric Antigen Receptor Cell Therapy Market: Transplant Rejection (2018-2023) & ($ Millions)
Figure 18. Chimeric Antigen Receptor Cell Therapy in Other
Figure 19. Global Chimeric Antigen Receptor Cell Therapy Market: Other (2018-2023) & ($ Millions)
Figure 20. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application in 2022
Figure 21. Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Player in 2022
Figure 22. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Regions (2018-2023)
Figure 23. Americas Chimeric Antigen Receptor Cell Therapy Market Size 2018-2023 ($ Millions)
Figure 24. APAC Chimeric Antigen Receptor Cell Therapy Market Size 2018-2023 ($ Millions)
Figure 25. Europe Chimeric Antigen Receptor Cell Therapy Market Size 2018-2023 ($ Millions)
Figure 26. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size 2018-2023 ($ Millions)
Figure 27. Americas Chimeric Antigen Receptor Cell Therapy Value Market Share by Country in 2022
Figure 28. United States Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 29. Canada Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 30. Mexico Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 31. Brazil Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 32. APAC Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Region in 2022
Figure 33. APAC Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type in 2022
Figure 34. APAC Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application in 2022
Figure 35. China Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 36. Japan Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 37. Korea Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 38. Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 39. India Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 40. Australia Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 41. Europe Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Country in 2022
Figure 42. Europe Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2018-2023)
Figure 43. Europe Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2018-2023)
Figure 44. Germany Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 45. France Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 46. UK Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 47. Italy Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 48. Russia Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 49. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Region (2018-2023)
Figure 50. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2018-2023)
Figure 51. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2018-2023)
Figure 52. Egypt Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 53. South Africa Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 54. Israel Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 55. Turkey Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 56. GCC Country Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 57. Americas Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 58. APAC Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 59. Europe Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 60. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 61. United States Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 62. Canada Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 63. Mexico Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Brazil Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 65. China Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 66. Japan Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 67. Korea Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 68. Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 69. India Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 70. Australia Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 71. Germany Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 72. France Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 73. UK Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 74. Italy Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 75. Russia Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 76. Spain Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 77. Egypt Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 78. South Africa Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 79. Israel Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 80. Turkey Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 81. GCC Countries Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 82. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 83. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Chimeric Antigen Receptor Cell Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Chimeric Antigen Receptor Cell Therapy Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Chimeric Antigen Receptor Cell Therapy Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Chimeric Antigen Receptor Cell Therapy Sales Market Share by Country/Region (2022)
Figure 8. Chimeric Antigen Receptor Cell Therapy Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type in 2022
Figure 10. Chimeric Antigen Receptor Cell Therapy in Acute Leukemia
Figure 11. Global Chimeric Antigen Receptor Cell Therapy Market: Acute Leukemia (2018-2023) & ($ Millions)
Figure 12. Chimeric Antigen Receptor Cell Therapy in Non-hodgkin's Lymphoma
Figure 13. Global Chimeric Antigen Receptor Cell Therapy Market: Non-hodgkin's Lymphoma (2018-2023) & ($ Millions)
Figure 14. Chimeric Antigen Receptor Cell Therapy in Multiple Myeloma
Figure 15. Global Chimeric Antigen Receptor Cell Therapy Market: Multiple Myeloma (2018-2023) & ($ Millions)
Figure 16. Chimeric Antigen Receptor Cell Therapy in Transplant Rejection
Figure 17. Global Chimeric Antigen Receptor Cell Therapy Market: Transplant Rejection (2018-2023) & ($ Millions)
Figure 18. Chimeric Antigen Receptor Cell Therapy in Other
Figure 19. Global Chimeric Antigen Receptor Cell Therapy Market: Other (2018-2023) & ($ Millions)
Figure 20. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application in 2022
Figure 21. Global Chimeric Antigen Receptor Cell Therapy Revenue Market Share by Player in 2022
Figure 22. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Regions (2018-2023)
Figure 23. Americas Chimeric Antigen Receptor Cell Therapy Market Size 2018-2023 ($ Millions)
Figure 24. APAC Chimeric Antigen Receptor Cell Therapy Market Size 2018-2023 ($ Millions)
Figure 25. Europe Chimeric Antigen Receptor Cell Therapy Market Size 2018-2023 ($ Millions)
Figure 26. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size 2018-2023 ($ Millions)
Figure 27. Americas Chimeric Antigen Receptor Cell Therapy Value Market Share by Country in 2022
Figure 28. United States Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 29. Canada Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 30. Mexico Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 31. Brazil Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 32. APAC Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Region in 2022
Figure 33. APAC Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type in 2022
Figure 34. APAC Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application in 2022
Figure 35. China Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 36. Japan Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 37. Korea Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 38. Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 39. India Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 40. Australia Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 41. Europe Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Country in 2022
Figure 42. Europe Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2018-2023)
Figure 43. Europe Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2018-2023)
Figure 44. Germany Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 45. France Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 46. UK Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 47. Italy Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 48. Russia Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 49. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Region (2018-2023)
Figure 50. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Type (2018-2023)
Figure 51. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size Market Share by Application (2018-2023)
Figure 52. Egypt Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 53. South Africa Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 54. Israel Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 55. Turkey Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 56. GCC Country Chimeric Antigen Receptor Cell Therapy Market Size Growth 2018-2023 ($ Millions)
Figure 57. Americas Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 58. APAC Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 59. Europe Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 60. Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 61. United States Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 62. Canada Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 63. Mexico Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 64. Brazil Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 65. China Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 66. Japan Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 67. Korea Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 68. Southeast Asia Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 69. India Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 70. Australia Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 71. Germany Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 72. France Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 73. UK Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 74. Italy Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 75. Russia Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 76. Spain Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 77. Egypt Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 78. South Africa Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 79. Israel Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 80. Turkey Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 81. GCC Countries Chimeric Antigen Receptor Cell Therapy Market Size 2024-2029 ($ Millions)
Figure 82. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share Forecast by Type (2024-2029)
Figure 83. Global Chimeric Antigen Receptor Cell Therapy Market Size Market Share Forecast by Application (2024-2029)
